Impact of menopause on outcomes in prolactinomas after dopamine agonist treatment withdrawal.

Sandhya SantharamAthanasios FountasMetaxia TampourlouWiebke ArltJohn AyukNeil GittoesAndrew ToogoodNiki Karavitaki

Published in: Clinical endocrinology (2018)

Prolactin normalized over time in nearly half of the women and serum PRL 6-12 months after DA withdrawal is useful predictor. Nonetheless, 7% of the patients demonstrated adenoma regrowth which, given the life expectancy postmenopause, necessitate regular monitoring of the cases with persistent hyperprolactinaemia.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
type diabetes
metabolic syndrome
pregnant women
skeletal muscle
combination therapy
insulin resistance